RIZZUTO, MARIA ANTONIETTA

RIZZUTO, MARIA ANTONIETTA  

DIPARTIMENTO DI BIOTECNOLOGIE E BIOSCIENZE  

Mostra records
Risultati 1 - 17 di 17 (tempo di esecuzione: 0.022 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in Cancer Cells 01 - Articolo su rivista 2014 BELLINI, MICHELAMAZZUCCHELLI, SERENAGALBIATI, ELISABETTAFiandra, LRIZZUTO, MARIA ANTONIETTACOLOMBO, MIRIAMTORTORA, PAOLOPROSPERI, DAVIDE +
Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity 01 - Articolo su rivista 2017 BELLINI, MICHELAFIANDRA, LUISARIZZUTO, MARIA ANTONIETTAPROSPERI, DAVIDE +
H-Ferritin Enriches the Curcumin Uptake and Improves the Therapeutic Efficacy in Triple Negative Breast Cancer Cells 01 - Articolo su rivista 2017 Pandolfi, LauraBellini, MichelaAvvakumova, SvetlanaBertolini, Jessica ArmidaRizzuto, Maria AntoniettaColombo, MiriamProsperi, Davide +
Metronomic nanocaged doxorubicin prevents chemoresistance and cardiotoxicity in breast cancer 02 - Intervento a convegno 2017 Bellini M.Rizzuto M. A.Prosperi D. +
H-Ferritin-nanocaged olaparib: A promising choice for both BRCA-mutated and sporadic triple negative breast cancer 01 - Articolo su rivista 2017 Bellini, M.Rizzuto, M. A.Prosperi, D. +
Half-Chain Cetuximab Nanoconjugates Allow Multitarget Therapy of Triple Negative Breast Cancer 01 - Articolo su rivista 2018 Colombo, MiriamRIZZUTO, MARIA ANTONIETTAPandolfi, LauraGiustra, MarcoGarbujo, StefaniaFiandra, LuisaProsperi, Davide +
Impact of the strategy adopted for drug loading in nonporous silica nanoparticles on the drug release and cytotoxic activity 01 - Articolo su rivista 2018 Riva, BenedettaBellini, MichelaVerderio, PaoloColzani, BarbaraAvvakumova, SvetlanaRizzuto, Maria AntoniettaColombo, MiriamProsperi, Davide +
Cetuximab-conjugates nanoparticles for the treatment of triple negative breast cancer 02 - Intervento a convegno 2019 Colombo M.Rizzuto M. A.Pandolfi L.Fiandra L.Prosperi D. +
Does conjugation strategy matter? Cetuximab-conjugated gold nanocages for targeting triple-negative breast cancer cells 01 - Articolo su rivista 2019 Avvakumova S.Pandolfi L.Bellini M.Galbiati E.Rizzuto M. A.Colombo M.Prosperi D. +
Thirty years of cancer nanomedicine: Success, frustration, and hope 01 - Articolo su rivista 2019 Salvioni L.Rizzuto M. A.Bertolini J. A.Colombo M.Prosperi D. +
Are nanotechnological approaches the future of treating inflammatory diseases? 01 - Articolo su rivista 2019 Rizzuto M. A.Salvioni L.Rotem R.Colombo M.Zanoni I.Granucci F.Prosperi D.
Exploiting Nanotechnology to Improve Cancer Immunotherapy and Overcome Biological Barriers 07 - Tesi di dottorato Bicocca post 2009 2019 RIZZUTO, MARIA ANTONIETTA
Engineered Ferritin Nanoparticles for the Bioluminescence Tracking of Nanodrug Delivery in Cancer 01 - Articolo su rivista 2020 Bellini M.Riva B.Rizzuto M. A.Salvioni L.Colombo M.Mingozzi F.Marongiu L.Frascotti G.Prosperi D.Fiandra L. +
Modeling the interaction of amphiphilic polymer nanoparticles with biomembranes to Guide rational design of drug delivery systems 01 - Articolo su rivista 2020 Rotem R.Rizzuto M. A.Giustra M.Salvioni L.Prosperi D.Colombo M. +
H-Ferritin nanoparticle-mediated delivery of antibodies across a BBB in vitro model for treatment of brain malignancies 01 - Articolo su rivista 2021 Rizzuto, Maria AntoniettaDal Magro, RobertaBarbieri, LindaPandolfi, LauraSalvioni, LuciaColombo, MiriamRe, FrancescaProsperi, Davide +
Evaluation of tfr-1 expression in feline mammary cancer and in vitro antitumor efficacy study of doxorubicin-loaded h-ferritin nanocages 01 - Articolo su rivista 2021 Prosperi D.Rizzuto M. A.Bellini M. +
Selective Targeting of Cancer-Associated Fibroblasts by Engineered H-Ferritin Nanocages Loaded with Navitoclax 01 - Articolo su rivista 2021 Rizzuto, Maria AntoniettaProsperi, Davide +